Introduction Henan Topfond Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the manufacturing and distribution of various drugs. The company's operations include the production, processing, and marketing of drug substances and drug products, as well as the research, development, and trading of APIs, intermediates, and both western and traditional Chinese finished dosage forms. In addition, the company actively works on developing new products. Established in 1969, Henan Topfond Pharmaceutical Co., Ltd. is headquartered in Zhumadian, China. |
Disease Domain | Count |
---|---|
Infectious Diseases | 2 |
Neoplasms | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 4 |
Herbal medicine | 1 |
Target- |
Mechanism- |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date08 Nov 2019 |
Mechanism Bacterial DNA gyrase inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1996 |
Mechanism alpha-tubulin inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1989 |
Start Date05 Aug 2024 |
Sponsor / Collaborator |
Start Date08 Jul 2024 |
Sponsor / Collaborator |
Start Date28 Jun 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Fleroxacin ( Bacterial DNA gyrase x Topoisomerase IV ) | Bacterial Infections More | Approved |
Chaihu Oral Liquid | Uterine Prolapse More | Approved |
TPN729MA ( PDE5A ) | Erectile Dysfunction More | Phase 3 |
YPS345 | Radiation Pneumonitis More | Phase 2 |
Vinorelbine Tartrate ( alpha-tubulin x β-tubulin ) | Advanced Malignant Solid Neoplasm More | Phase 1 |